Retatrutide

Retatrutide is a next-generation peptide currently in clinical development for weight loss and metabolic health. It acts as a triple agonist, targeting GLP-1, GIP, and glucagon receptors to significantly reduce appetite, improve blood sugar control, and enhance fat burning. Early studies show promising results in promoting substantial and sustained weight loss, making Retatrutide a potential breakthrough in obesity and diabetes treatment.